• Profile
Close

Urinary biomarkers profiles in patients with neurogenic detrusor overactivity according to their neurological condition

World Journal of Urology Nov 21, 2019

Richard C, Bendavid C, Hascoet J, et al. - A prospective single-center study was carried out between March 2015 and March 2017 on individuals aged over 18 years old, with neurological disease, with a urodynamic diagnosis of neurogenic detrusor overactivity (NDO) in order to examine the disease-specific urinary levels differences of neurotrophins (NGF, BDNF), mediators of inflammation (TGFβ-1, PGE-2) and markers of extracellular matrix alterations in individuals with multiple sclerosis (MS) spinal cord injury (SCI), or spina bifida, and NDO. Forty-one individuals were involved, ie, six with MS, 20 with SCI, and 15 with spina bifida. It was observed that all NDO may not be made even from a molecular standpoint. Compared with those in other neurologic populations with NDO, greater urinary levels of neurotrophins were noted in MS individuals. In comparison with SCI persons, urinary TGFβ-1, a robust determinant of the extracellular matrix, was notably greater in spina bifida individuals. Thus, these findings emphasize the significance of using and explaining those potential urinary markers in a disease-specific fashion.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay